PUBLISHER: Grand View Research | PRODUCT CODE: 1869808
PUBLISHER: Grand View Research | PRODUCT CODE: 1869808
The global veterinary oxygen therapy market size was estimated at USD 1.29 billion in 2024 and is projected to reach USD 2.47 billion by 2033, growing at a CAGR of 7.63% from 2025 to 2033. The market is experiencing growth driven by the rising prevalence of respiratory and critical conditions in animals, the expansion of veterinary infrastructure and specialized clinics, and advancements in veterinary essential care technologies.
Increasing cases of pneumonia, asthma, cardiac failure, and trauma-induced hypoxemia in companion animals, along with better diagnostic tools, highlight the need for respiratory support. Rising prevalence of respiratory diseases in companion animals and increasing efforts to combat disease outbreaks are expected to fuel market growth rapidly. Veterinarians across the U.S. have reported outbreaks of a canine respiratory illness in August 2023, that do not respond to standard treatments and appears more severe and prolonged than typical canine infectious respiratory disease (CIRD). The exact cause remains unknown. In response, Cornell University's College of Veterinary Medicine, through its Animal Health Diagnostic Center and Riney Canine Health Center, launched a rapid response research project to investigate this disease and develop effective therapeutics for its cure.
In addition, adopting oxygen therapy plays a vital role in stabilizing patients in emergencies and post-surgical care. Clinics and hospitals must invest in oxygen cages, masks, and concentrators. This demand increases veterinary oxygen equipment sales, increases adoption rates, and propels businesses to develop innovative, portable solutions. The market is growing because of the quick advancements in oxygen delivery and monitoring technologies in contemporary veterinary care, such as integrated anesthetic equipment, portable oxygen concentrators, and flow regulators.
Manufacturers are constantly developing small, cost-effective, and easy-to-use products that allow even mobile units and small clinics to offer top-notch care. For instance, in January 2025, Super Air Smart ICU was introduced by Bionet America, Inc., with effective oxygenation, CO2 removal without soda-lime, air purification, and sophisticated climate control that improves the dependability of critical care. These innovations reduce operational complexity and enhance treatment reliability, encouraging veterinarians to adopt oxygen therapy widely. Improved outcomes boost pet owner confidence, leading to greater acceptance of oxygen-based interventions. The availability of diverse, advanced solutions broadens usage across companion, equine, and livestock practices, fueling market expansion.
Furthermore, with the help of government programs and private investments, there is an increasing number of veterinary hospitals, referral centers, and specialist clinics. The services in rural regions are growing with portable oxygen equipment, and the urban cities have emergency rooms and veterinary intensive care units. The expansion of this infrastructure increases the accessibility of oxygen therapy for both livestock farmers and pet owners. Adoption of modern oxygen equipment is fueled by competition among clinics to provide advanced services. In addition, the proliferation of specialist institutions normalizes oxygen therapy as a component of routine veterinary care.
Global Veterinary Oxygen Therapy Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global veterinary oxygen therapy market report based on product, animal, application, end use, and region: